{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T09:56:21Z","timestamp":1794995781685,"version":"4.9.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jocn.2026.111928","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:25:01Z","timestamp":1770956701000},"page":"111928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Bone Microenvironment and Therapeutic Resistance in Spinal Metastases: Mechanisms and Clinical Implications"],"prefix":"10.1016","volume":"147","author":[{"given":"Laura","family":"Mittelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Abikenari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Latzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Rangavajhula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoaib","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon A.","family":"Santhumayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Duehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Cassimatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Caridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Fu Larry","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Sciubba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy S.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.14245\/ns.2244290.145","article-title":"Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy","volume":"19","author":"Fomchenko","year":"2022","journal-title":"Neurospine"},{"key":"10.1016\/j.jocn.2026.111928_b0010","doi-asserted-by":"crossref","unstructured":"Nater A, Sahgal A, Fehlings M. Management \u2013 spinal metastases. In: Handbook of Clinical Neurology [Internet]. Elsevier; 2018 [cited 2025 Nov 17]. p. 239\u201355. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128111611000165.","DOI":"10.1016\/B978-0-12-811161-1.00016-5"},{"issue":"2","key":"10.1016\/j.jocn.2026.111928_b0015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncr.20756","article-title":"for the Dutch Bone Metastasis Study Group. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy","volume":"103","author":"Van Der Linden","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2026.111928_b0020","unstructured":"Ziu E, Viswanathan VK, Mesfin FB. Spinal Metastasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Nov 17]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441950\/."},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-194007000-00016","article-title":"THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES","volume":"112","author":"Batson","year":"1940","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.jocn.2026.111928_b0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/1097-0142(195105)4:3<610::AID-CNCR2820040312>3.0.CO;2-Q","article-title":"The role of the vertebral venous system in the metastasis of cancer to the spinal column; experiments with tumor-cell suspensions in rats and rabbits","volume":"4","author":"Coman","year":"1951","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2026.111928_b0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4615-3398-6_8","article-title":"Role of the vertebral venous system in metastatic spread of cancer cells to the bone","volume":"324","author":"Harada","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jocn.2026.111928_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/nop\/npaa046","article-title":"Epidemiology of spinal cord and column tumors","author":"Wewel","year":"2020","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.jocn.2026.111928_b0045","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/CGM.S12769","article-title":"The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer","volume":"6","author":"Dushyanthen","year":"2013","journal-title":"Cancer Growth Metastasis"},{"key":"10.1016\/j.jocn.2026.111928_b0050","doi-asserted-by":"crossref","unstructured":"David Roodman G, Silbermann R. Mechanisms of osteolytic and osteoblastic skeletal lesions. BoneKEy Rep [Internet]. 2015 Oct 28 [cited 2025 Nov 17];4. Available from: http:\/\/www.portico.org\/Portico\/article?article=pgk2ph9kgvp.","DOI":"10.1038\/bonekey.2015.122"},{"issue":"14","key":"10.1016\/j.jocn.2026.111928_b0055","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-07-6541","article-title":"Prostate Cancer Induces Bone Metastasis through Wnt-Induced Bone Morphogenetic Protein-Dependent and Independent Mechanisms","volume":"68","author":"Dai","year":"2008","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tranon.2018.04.013","article-title":"DKK1 and Kremen Expression Predicts the Osteoblastic Response to Bone Metastasis","volume":"11","author":"Clines","year":"2018","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2026.111928_b0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5306\/wjco.v5.i3.263","article-title":"Diagnosis and surgical management of breast cancer metastatic to the spine","volume":"5","author":"Ju","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.jocn.2026.111928_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.suronc.2020.03.005","article-title":"Spinal metastases from lung cancer: Survival depends only on genotype, neurological and personal status, scarcely of surgical resection","volume":"34","author":"Amelot","year":"2020","journal-title":"Surg Oncol"},{"issue":"22","key":"10.1016\/j.jocn.2026.111928_b0075","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for Metastatic Castration-Resistant Prostate Cancer","volume":"382","author":"De Bono","year":"2020","journal-title":"N Engl J Med"},{"issue":"10295","key":"10.1016\/j.jocn.2026.111928_b0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(21)00580-8","article-title":"Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial","volume":"398","author":"Sweeney","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jocn.2026.111928_b0085","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.3390\/cancers16183152","article-title":"Therapeutic Opportunities for Biomarkers in Metastatic Spine Tumors","volume":"16","author":"Schroeder","year":"2024","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.jocn.2026.111928_b0090","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1097\/00007632-199610010-00012","article-title":"Anatomic distribution of metastases in the vertebral body and modes of hematogenous spread","volume":"21","author":"Yuh","year":"1996","journal-title":"Spine"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0095","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3390\/ijms24043785","article-title":"The Role of Cytokines in the Metastasis of Solid Tumors to the Spine: Systematic Review","volume":"24","author":"\u0141ab\u0119d\u017a","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jocn.2026.111928_b0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.jocn.2026.111928_b0105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jocn.2026.111928_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2025.112454","article-title":"Differential human bone remodeling rates and implications for the temporal resolution of geoprofiling isotopes","volume":"370","author":"Quinn","year":"2025","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jocn.2026.111928_b0115","doi-asserted-by":"crossref","DOI":"10.2174\/1389450117666161226121650","article-title":"Bone: a Fertile Soil for Cancer Metastasis","author":"Coughlin","year":"2017","journal-title":"Curr Drug Targets [Internet]"},{"key":"10.1016\/j.jocn.2026.111928_b0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2015.11.017","article-title":"Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer","volume":"99","author":"Futakuchi","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jocn.2026.111928_b0125","article-title":"Physiopathology of spine metastasis","volume":"2011","author":"Maccauro","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.jocn.2026.111928_b0130","unstructured":"Jayarangaiah A, Kemp AK, Theetha Kariyanna P. Bone Metastasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2026 Jan 6]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507911\/."},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-007-9109-4","article-title":"The bone microenvironment in metastasis; what is special about bone?","volume":"27","author":"Bussard","year":"2008","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41413-020-00105-1","article-title":"Molecular mechanisms and clinical management of cancer bone metastasis","volume":"8","author":"Wang","year":"2020","journal-title":"Bone Res"},{"key":"10.1016\/j.jocn.2026.111928_b0145","unstructured":"Greenblatt M, Sun J, Hu L, Bok S, Yallowitz A, Cung M, et al. Discovery of a Vertebral Skeletal Stem Cell Driving Spinal Metastases [Internet]. 2023 [cited 2026 Jan 6]. Available from: https:\/\/www.researchsquare.com\/article\/rs-2106142\/v1."},{"key":"10.1016\/j.jocn.2026.111928_b0150","doi-asserted-by":"crossref","unstructured":"Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar R, et al. NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw. 2013 Aug;11(suppl 3):S-1-S-50.","DOI":"10.6004\/jnccn.2013.0215"},{"key":"10.1016\/j.jocn.2026.111928_b0155","doi-asserted-by":"crossref","unstructured":"Tahara RK, Brewer TM, Theriault RL, Ueno NT. Bone Metastasis of Breast Cancer. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance [Internet]. Cham: Springer International Publishing; 2019 [cited 2025 Nov 17]. p. 105\u201329. (Advances in Experimental Medicine and Biology; vol. 1152). Available from: http:\/\/link.springer.com\/10.1007\/978-3-030-20301-6_7.","DOI":"10.1007\/978-3-030-20301-6_7"},{"issue":"9","key":"10.1016\/j.jocn.2026.111928_b0160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","article-title":"Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer","volume":"39","author":"Zhang","year":"2019","journal-title":"Cancer Commun"},{"issue":"6","key":"10.1016\/j.jocn.2026.111928_b0170","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143764","article-title":"Exploiting bone niches: progression of disseminated tumor cells to metastasis","volume":"131","author":"Muscarella","year":"2021","journal-title":"J Clin Invest"},{"issue":"Pt 1","key":"10.1016\/j.jocn.2026.111928_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/icb.1988.5","article-title":"Specific in vitro anti-tumour activity of methotrexate-monoclonal antibody conjugates prepared using human serum albumin as an intermediary","volume":"66","author":"Pietersz","year":"1988","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.canlet.2015.10.033","article-title":"The bone marrow niche in support of breast cancer dormancy","volume":"380","author":"Walker","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jocn.2026.111928_b0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.lfs.2018.06.036","article-title":"Wnt signaling in bone metastasis: mechanisms and therapeutic opportunities","volume":"208","author":"Li","year":"2018","journal-title":"Life Sci"},{"issue":"7483","key":"10.1016\/j.jocn.2026.111928_b0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jocn.2026.111928_b0195","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-\u03b22 dictates disseminated tumour cell fate in target organs through TGF-\u03b2-RIII and p38\u03b1\/\u03b2 signalling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"13","key":"10.1016\/j.jocn.2026.111928_b0200","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20110840","article-title":"Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone","volume":"208","author":"Kobayashi","year":"2011","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jocn.2026.111928_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10125","article-title":"Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities","volume":"3","author":"Byrne","year":"2019","journal-title":"JBMR Plus"},{"issue":"489","key":"10.1016\/j.jocn.2026.111928_b0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2020.06.004","article-title":"Hypoxia in bone metastasis and osteolysis","volume":"1","author":"Todd","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jocn.2026.111928_b0215","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3389\/fimmu.2019.01719","article-title":"T Cell Dysfunction in Cancer Immunity and Immunotherapy","volume":"10","author":"Xia","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jocn.2026.111928_b0220","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jocn.2026.111928_b0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2018.03.025","article-title":"Dysfunction of antigen processing and presentation by dendritic cells in cancer","volume":"113","author":"Bandola-Simon","year":"2019","journal-title":"Mol Immunol"},{"issue":"17","key":"10.1016\/j.jocn.2026.111928_b0230","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","article-title":"Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jocn.2026.111928_b0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jocn.2026.111928_b0240","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8970173","article-title":"Immune Checkpoint Inhibitor Therapy for Bone Metastases: specific Microenvironment and Current Situation","volume":"2021","author":"Liu","year":"2021","journal-title":"J Immunol Res"},{"issue":"16","key":"10.1016\/j.jocn.2026.111928_b0245","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","article-title":"LAG-3 and PD-1 synergize on CD8+ Tcells to drive T cell exhaustion and hinder autocrine IFN-\u03b3-dependent anti-tumor immunity","volume":"187","author":"Andrews","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jocn.2026.111928_b0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40364-020-0185-8","article-title":"Increased PD-1+Tim-3+ exhausted T cells in bone marrow may influence the clinical outcome of patients with AML","volume":"8","author":"Tan","year":"2020","journal-title":"Biomark Res"},{"issue":"22","key":"10.1016\/j.jocn.2026.111928_b0255","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.3390\/cancers14225656","article-title":"Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes","volume":"14","author":"Kouroukli","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.jocn.2026.111928_b0260","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cac2.12596","article-title":"Dysfunction of dendritic cells in tumor microenvironment and immunotherapy","volume":"44","author":"Chen","year":"2024","journal-title":"Cancer Commun Lond Engl"},{"issue":"7","key":"10.1016\/j.jocn.2026.111928_b0265","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.jocn.2026.111928_b0270","first-page":"177","article-title":"Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies","volume":"3","author":"Tawara","year":"2011","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jocn.2026.111928_b0275","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","article-title":"Classical and Paradoxical Effects of TNF-\u03b1 on Bone Homeostasis","volume":"5","author":"Osta","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2026.111928_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2023.100505","article-title":"Immune checkpoint inhibitors in bone metastasis: Clinical challenges, toxicities, and mechanisms","volume":"43","author":"Joseph","year":"2023","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.jocn.2026.111928_b0285","article-title":"Contribution of the immune bone marrow microenvironment to tumor growth and bone deconstruction: implications for improving immunotherapeutic strategies in bone metastasis","volume":"69","author":"Massy","year":"2025","journal-title":"Neoplasia N Y N"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11914-025-00934-1","article-title":"Cancer Cell Dormancy in the Bone Microenvironment","volume":"23","author":"Harris","year":"2025","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocn.2026.111928_b0295","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fonc.2020.00335","article-title":"The Endosteal Niche in Breast Cancer Bone Metastasis","volume":"10","author":"Haider","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2026.111928_b0300","volume":"11","author":"Riquelme","year":"2020","journal-title":"Osteocytes and Bone Metastasis Front Endocrinol"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0305","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jocn.2026.111928_b0310","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ncb2767","article-title":"The perivascular niche regulates breast tumour dormancy","volume":"15","author":"Ghajar","year":"2013","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0315","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","article-title":"Mechanisms governing metastatic dormancy and reactivation","volume":"155","author":"Giancotti","year":"2013","journal-title":"Cell"},{"issue":"39","key":"10.1016\/j.jocn.2026.111928_b0320","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1073\/pnas.1113483108","article-title":"Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation","volume":"108","author":"Wong","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"7069","key":"10.1016\/j.jocn.2026.111928_b0325","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jocn.2026.111928_b0330","doi-asserted-by":"crossref","first-page":"172","DOI":"10.37349\/etat.2022.00078","article-title":"Role of PI3K\/Akt\/mTOR pathway in mediating endocrine resistance: concept to clinic","volume":"3","author":"Skolariki","year":"2022","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"10.1016\/j.jocn.2026.111928_b0335","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy292.080","article-title":"Bone metastasis reduces responsiveness to EGFR-TKIs in patients with EGFR-mutated advanced lung adenocarcinoma","volume":"29","author":"Zheng","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.jocn.2026.111928_b0340","doi-asserted-by":"crossref","first-page":"e7152","DOI":"10.1002\/cam4.7152","article-title":"Assessing EGFR \u2010mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy","volume":"13","author":"Chen","year":"2024","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.jocn.2026.111928_b0345","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11912-009-0015-5","article-title":"VHL gene mutations in renal cell carcinoma: Role as a biomarker of disease outcome and drug efficacy","volume":"11","author":"Cowey","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jocn.2026.111928_b0350","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/IJN.S442768","article-title":"Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: recent advances and challenges","volume":"19","author":"Yu","year":"2024","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-023-01272-6","article-title":"Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions","volume":"16","author":"Mei","year":"2024","journal-title":"Genome Med"},{"issue":"6","key":"10.1016\/j.jocn.2026.111928_b0360","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ijms17060987","article-title":"Bone Metastasis from Renal Cell Carcinoma","volume":"17","author":"Chen","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jocn.2026.111928_b0365","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ijc.25981","article-title":"Osteoblast\u2010secreted factors enhance the expression of dysadherin and CCL2\u2010dependent migration of renal carcinoma cells","volume":"130","author":"Sch\u00fcler","year":"2012","journal-title":"Int J Cancer"},{"issue":"7495","key":"10.1016\/j.jocn.2026.111928_b0370","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.jocn.2026.111928_b0375","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic Mechanisms responsible for Osteolytic and Osteoblastic Bone Metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jocn.2026.111928_b0380","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.eururo.2022.09.010","article-title":"Emergence of BRCA Reversion Mutations in patients with Metastatic Castration-resistant Prostate Cancer after Treatment with Rucaparib","volume":"83","author":"Loehr","year":"2023","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41388-024-03227-6","article-title":"Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms","volume":"44","author":"Jain","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jocn.2026.111928_b0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s11658-025-00774-y","article-title":"Modeling the effects of radiation on the bone tumor microenvironment: opportunities for exploring combination therapies in microphysiologic systems","volume":"30","author":"Jackett","year":"2025","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jocn.2026.111928_b0395","doi-asserted-by":"crossref","unstructured":"Ferini *Gianluca, Palmisciano P, Scalia G, Haider AS, Bin-Alamer O, Sagoo NS, et al. The role of radiation therapy in the treatment of spine metastases from hepatocellular carcinoma: a systematic review and meta-analysis. Neurosurg Focus. 2022 Nov;53(5):E12.","DOI":"10.3171\/2022.8.FOCUS2255"},{"issue":"11","key":"10.1016\/j.jocn.2026.111928_b0400","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clon.2020.07.010","article-title":"Spine and Non-spine Bone Metastases \u2013 Current Controversies and Future direction","volume":"32","author":"Challapalli","year":"2020","journal-title":"Clin Oncol"},{"issue":"8","key":"10.1016\/j.jocn.2026.111928_b0405","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/cancers17081296","article-title":"Current Concepts in the Management and Treatment of Spinal Metastases\u2014A Systematic Literature Review","volume":"17","author":"Palacio Giraldo","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jocn.2026.111928_b0410","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40778-017-0099-z","article-title":"Radiation-Induced Bone Toxicity","volume":"3","author":"Okoukoni","year":"2017","journal-title":"Curr Stem Cell Rep"},{"key":"10.1016\/j.jocn.2026.111928_b0415","doi-asserted-by":"crossref","unstructured":"Coimbra BGMM, Silva ARN de SE, Soares CB, Figueiredo CCN de, Macamo MS, Cristante AF. Advances in Radiotherapy in the Treatment of Metastatic Spinal Lesions. Rev Bras Ortop. 2025 Jun;60(3):s00451810030.","DOI":"10.1055\/s-0045-1810030"},{"key":"10.1016\/j.jocn.2026.111928_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1467602","article-title":"Targeting extracellular matrix stiffness for cancer therapy","volume":"15","author":"Feng","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jocn.2026.111928_b0425","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov"},{"issue":"9","key":"10.1016\/j.jocn.2026.111928_b0430","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/pharmaceutics16091207","article-title":"Biological Barriers for Drug delivery and Development of innovative Therapeutic Approaches in HIV, Pancreatic Cancer, and Hemophilia A\/B","volume":"16","author":"Basar","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826000792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:52:43Z","timestamp":1772628763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826000792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":86,"alternative-id":["S0967586826000792"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111928","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Bone Microenvironment and Therapeutic Resistance in Spinal Metastases: Mechanisms and Clinical Implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.111928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111928"}}